Publications by authors named "K Hengst"

Article Synopsis
  • Oxidative stress is linked to chronic diseases, and improving it through lifestyle changes can help prevent and treat these conditions.
  • This systematic review analyzed studies from the last decade on lifestyle interventions and oxidative stress biomarkers, focusing on glutathione, superoxide dismutase, catalase, and malondialdehyde.
  • Nine relevant studies showed that dietary and exercise changes can increase superoxide dismutase and catalase levels while decreasing malondialdehyde in individuals with non-communicable diseases, although the results varied due to different methods used in the studies.
  • The review emphasizes the need for more long-term studies to fully understand how lifestyle changes impact oxidative stress and its role in chronic disease management.
View Article and Find Full Text PDF

Stress-eating (eating more or more unhealthily in order to accommodate to stress), contributes to the development and maintenance of obesity. The effect of comprehensive weight loss interventions on changes in stress-eating as well as the contributing role of stress-eating on weight reduction has not been examined. The impact of the 8-week intensive phase of the Healthy Lifestyle Community Programme (HLCP, cohort 1) on emotional, external and restrained eating, as expressions of stress-eating was evaluated in a non-randomized controlled trial.

View Article and Find Full Text PDF

Stress and cortisol dysregulation are linked to NCDs. Moreover, stress favours unhealthy lifestyle patterns, which increase the risk for NCDs. The role of the Cortisol Awakening Response (CAR) and the effect of lifestyle interventions on the same remain unclear.

View Article and Find Full Text PDF

Background: The potential of adopting a healthy lifestyle to fight non-communicable diseases (NCDs) is not fully used. We hypothesised that the Healthy Lifestyle Community Programme (HLCP, cohort 1) reduces weight and other risk markers compared with baseline and control.

Methods: 24-month, non-randomised, controlled intervention trial.

View Article and Find Full Text PDF

Background: Crohn's Disease (CD) is typically characterized by abdominal symptoms, however, besides gastrointestinal symptoms, CD patients may suffer from extraintestinal manifestations which are far less common and medical treatment can be challenging.

Case Presentation: We report about a 34-year-old Crohn's Disease (CD) patient in clinical remission under adalimumab therapy who presented in the clinic for Cranio-Maxillo Surgery due to severe pain in the mandibular area. Ulcerative lesions of the buccal-side mucosa of the right mandible were detected.

View Article and Find Full Text PDF